Peter Collins
Overview
Explore the profile of Peter Collins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
5057
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Webb C, George M, Collins P
Eur Heart J Open
. 2025 Mar;
5(2):oeaf016.
PMID: 40084149
No abstract available.
2.
Gardner M, Bowden C, Manzoor S, Cozier G, Andrews R, Craft S, et al.
ACS Omega
. 2025 Mar;
10(8):7839-7847.
PMID: 40060840
Synthetic cannabinoids (SCs) are novel psychoactive substances (NPS) that are highly potent and associated with a range of severe toxicities. SC use, which is common in UK prisons and homeless...
3.
Manolis A, Collins P, Kallistratos M, Rosano G
Hellenic J Cardiol
. 2025 Feb;
PMID: 39987952
The updated guideline empowers physicians to tailor treatment plans more effectively to individual patient characteristics, preferences, and responses. With a more flexible and individualized approach to angina management, seems that...
4.
Ahmed R, Ahmed M, Khlidj Y, Rehman O, Al-Mukhtar L, Abou Khater N, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685921
The epidemiological data regarding mortality rates of adults with sarcoidosis and non-ischemic cardiovascular disease (CVD) are limited. A retrospective observational analysis was conducted to identify trends and disparities related to...
5.
Okafor J, Azzu A, Ahmed R, Ohri S, Wechalekar K, Wells A, et al.
Open Heart
. 2024 Oct;
11(2).
PMID: 39462525
Background: Echocardiography, cardiac magnetic resonance and cardiac fluorodeoxyglucose positron emission tomography (FDG-PET) imaging play key roles in the diagnosis and management of cardiac sarcoidosis (CS), but the relative value of...
6.
Bell S, Taylor H, Pallmann P, Collins P
Anaesthesia
. 2024 Oct;
80(1):104-106.
PMID: 39454095
No abstract available.
7.
Singh Dulay M, Ahmed R, Liu A, Shi R, Okafor J, Azzu A, et al.
Curr Probl Cardiol
. 2024 Oct;
50(1):102892.
PMID: 39433145
Background: Cardiac Resynchronisation Therapy (CRT) has demonstrated short and long-term benefit in heart failure with reduced ejection fraction (HFrEF), including ischaemic (ICM) and non-ischaemic cardiomyopathy. However, there is a paucity...
8.
Liu A, Ahmed R, Singh Dulay M, Okafor J, Azzu A, Ramphul K, et al.
ESC Heart Fail
. 2024 Oct;
12(1):592-602.
PMID: 39419535
Aims: In cardiac sarcoidosis (CS) patients, the benefit of cardiac resynchronization therapy (CRT) remains unclear. We sought to assess the short-term and long-term effects of CRT in CS patients with...
9.
Elsmore A, Rai T, Pallmann P, Townson J, Kotecha S, Black M, et al.
Trials
. 2024 Sep;
25(1):629.
PMID: 39334250
Background: Obstetric Bleeding Study UK (OBS UK) (award ID: 152057) is a National Institute for Health and Care Research (NIHR)-funded stepped wedge cluster randomised controlled trial of a complex intervention...
10.
Outcomes of definite vs probable/presumed cardiac sarcoidosis: a systematic review and meta-analysis
Ahmed R, Ahsan A, Ahmed M, Dragon M, Caballero R, Tabassum S, et al.
Curr Probl Cardiol
. 2024 Aug;
49(12):102820.
PMID: 39191361
Background: Diagnosing cardiac sarcoidosis (CS), which can be associated with arrhythmias and heart failure, remains challenging despite multiple advances over time. The 2014 Heart Rhythm Society (HRS) consensus statement recommends...